Posts by: Patricia Inacio PhD

News

The Cancer Therapy & Research Center (CTRC) at the UT Health Science Center San Antonio was one of the few centers to receive the designation of a National Cancer Institute (NCI) Designated ... Read more

May 18, 2015May 18, 2015

Genentech Fostering Anti-PDL1 Immunotherapy in Lung Cancer

News

Genentech will present the most recent results on their ongoing developments for non-small cell lung cancer (NSCLC) at this years’ Annual Meeting of the American Society of Clinical Oncology (ASCO). ... Read more

May 15, 2015May 15, 2015

Melanoma-Activating Beta-Catenin Signalling Prevents Immune System Activation

News

In a new study entitled “Melanoma-intrinsic β-catenin signaling prevents anti-tumor immunity,” a research team at University of Chicago unraveled the mechanism by which melanoma tumors are able to resist to ... Read more

May 13, 2015May 13, 2015

Cancer Cells Disguise as Immune Cells to Form Metastases

News

In a new study entitled “TGF-β1-induced EMT promotes targeted migration of breast cancer cells through the lymphatic system by the activation of CCR7/CCL21-mediated chemotaxis,” researchers discovered how cancer cells travel ... Read more

May 12, 2015May 12, 2015

Novel Genentech Medicines for Cancer Treatment Presented at ASCO Meeting

News

During the American Society of Clinical Oncology (ASCO) Annual Meeting, taking place in Chicago, from 29 May to 2 June, Genentech will present the latest results on ten of its approved cancer and other ongoing ... Read more

May 11, 2015May 11, 2015

NanoString Technologies and Cancer Immunotherapy Trials Network (CITN) Establish Collaboration to Foster Cancer Immunotherapies

News

The Cancer Immunotherapy Trials Network (CITN) and NanoString Technologies, Inc. have recently announced they will collaborate to find biomarkers that predict clinical outcomes for cancer immunotherapies. According to CITN’s mission – to ... Read more

May 8, 2015May 8, 2015

Foxo1 Downregulates Anti-Tumor Activity of Natural Killer Cells

News

In a new study entitled “Transcription Factor Foxo1 Is a Negative Regulator of Natural Killer Cell Maturation and Function,” researchers at The Ohio State University Comprehensive Cancer Center identified Foxo1 ... Read more

May 6, 2015May 6, 2015

Foreign Antibodies Stimulate Immune System Against Cancer

News

In a new study entitled “Allogeneic IgG combined with dendritic cell stimuli induce antitumour T-cell immunity” published in Nature, a newly-designed strategy by researchers at Stanford University School of Medicine shows that mouse ... Read more

May 5, 2015May 5, 2015

Anti-CD47 Therapy Increases Macrophage Population Against Glioblastoma Multiforme

News

A new study entitled “M1 Macrophages Demonstrate a Superior Phagocytic Response Against Glioblastoma Multiforme Following Anti-CD47 Treatment” was recently presented at the 2015 edition of the American Association of Neurological ... Read more

May 4, 2015May 4, 2015

Depleting Immunosuppressive B Cells Allows Destruction of Advanced Prostate Tumors by Oxaliplatin

News

In a recent study entitled “Immunosuppressive plasma cells impede T-cell-dependent immunogenic chemotherapy,” researchers discovered that immunosuppressive B cells allow advanced prostate tumors to resist chemotherapy. The team showed that once ... Read more